Gelsingers, UPenn settle suit

URL: http://www.nature.com/cgi-taf/DynaPage.taf?file=/nbt/journal/v18/n12/full/nbt1200_1230a.html

Date accessed: 30 January 2001


In Brief

Go to TOC
 
 
Previous Article AbstractFULL TEXTNext Article Abstract
Full Text PDF  
 

 

Business and Regulatory News
 
December 2000 Volume 18 Number 12 p 1230
 
 
Gelsingers, UPenn settle suit
Jeffrey Fox
 


The lawsuit brought by Jesse Gelsinger's father and family members against several gene therapy researchers and administrators at the University of Pennsylvania (UPenn; Philadelphia, PA) was settled early in November. The wrongful death lawsuit, filed in September this year (Nat. Biotechnol. 18, 1136, 2000), was triggered following Gelsinger's death a year earlier while he participated in a gene therapy clinical trial (Nat. Biotechnol. 17, 1153, 1999;MEDLINE). Although the settlement amount remains confidential, the family praised the university for "taking seriously the need for research universities to improve the conditions under which clinical research is conducted" and said that this attitude "meant a great deal in resolving this case." As part of the negotiations, the family also dismissed claims against UPenn bioethicist Arthur Caplan and former medical dean William Kelley.

 
   

Home

Site GuideFeedback

Category: 50. Gene Therapy, Genetic Research, and Genetically Modified Species